Among the 28 subjects that were newly enrolled with PSA levels lower than 20 ng/ml, the LBXexo score correctly identified 100% of high-grade prostate cancer subjects GS ≥ 7 and all low-grade prostate cancer subjects (GS = 6) (Table 5). This evidence concerns the gene KLK3 and prostate cancer.